Clinical Trials · NCT01656629

Stem Cell Recruitment in Osteoporosis Therapy

Phase
N/A
Recruitment status
Terminated
Sponsor
Johns Hopkins University
Enrollment
55
Start date
Aug 2012
Locations
1 site, United States
Primary endpoint
The Percent Change in Circulating Osteoprogenitor Cells as Assessed by Flow Cytometry in the Blood Before and After Treatment With Parathyroid Hormone (PTH) or Alendronate (ALN).
View Teriparatide compound reference